Apimeds Pharmaceuticals US, Inc. filed 3 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-05-05. Between them they name 1 person. Each change below is quoted from the filing and linked to it.
Every change, newest first
Appointed: Sungjoon Chae, Chief Executive Officer
On May 4, 2026, pursuant to a nomination by a stockholder of Apimeds Pharmaceuticals US, Inc., a Delaware corporation (the " Company "), the board of directors of the Company (the " Board ") appointed Sungjoon Chae to serve as Co-Chief Executive Officer of the Company, effective as of such date.
Reported
Under the Settlement Agreement, the Inscobee Parties have agreed to secure the resignation or removal of Mr. Koo.
Reported
The Stockholder Consent, including the Board Removals, the Officer Removals, and the purported appointment of replacement directors, is null and void, having been taken in direct violation of binding contractual obligations under the Support Agreement (as defined below) and applicable Delaware law.
Find people with the same kind of experience as the Chief Executive Officer at Apimeds Pharmaceuticals US, Inc., with the record behind each one.
Find candidates like Chief Executive Officer at Apimeds Pharmaceuticals US, Inc.New leaders review vendors and budgets in their first months. Get an alert the next time Apimeds Pharmaceuticals US, Inc. is in the news or changes leadership.
Get an alert when Apimeds Pharmaceuticals US, Inc. changes leadershipTools for this story
Each opens in a new tab, filled in for Apimeds Pharmaceuticals US, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.